Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Submitted by
admin
on August 1, 2018 - 10:35am
Source:
CP Wire
News Tags:
Clover BioPharmaceuticals
Enbrel
Amgen
biosimilars
SCB-808
China
Headline:
Clover Initiates Ph I Study of Enbrel Biosimilar in China
snippet:
Currently available Enbrel biosimilars in China were not compared to the originator
Current biosimilars only available in lyophilized powder
SCB-808 will be available in pre-filled syringes
Do Not Allow Advertisers to Use My Personal information
